Accurate prediction of peptide structures and peptide-receptor complexes is essential for rational peptide drug development. However, the inherent conformational flexibility of short and disordered peptides presents a fundamental challenge. The AlphaFold model series, which has progressed from AlphaFold2 through AlphaFold-Multimer to AlphaFold3, has substantially advanced computational peptide structure prediction through innovations in geometric reasoning (invariant point attention) and interface-focused confidence metrics (ipTM score), achieving high accuracy for both monomeric peptide structures and multi-chain complexes. However, these models output static conformations, whereas many bioactive peptides adopt their functional conformations only upon binding-often corresponding to low-probability states that static predictions may overlook, leading to failures in virtual screening. This review synthesizes recent advances in the AlphaFold series for peptide studies and applications, discusses their current strengths in structure prediction and receptor-binding analysis, and examines the limitations in capturing conformational dynamics, transient interactions, and chemical modifications. Recent studies have suggested that integrated computational strategies that combine AlphaFold predictions with molecular dynamics simulations, free energy calculations, and ensemble sampling to enhance predictive accuracy and better represent the dynamic nature of peptide-drug interactions. These complementary approaches position AlphaFold as a central computational platform in structure-guided peptide drug design, enabling more efficient lead identification and optimization while bridging the gap between static computational predictions and the complex biophysical reality of peptide therapeutics.
A comprehensive benchmarking of five state-of-the-art protein structure prediction models demonstrates that prediction accuracy systematically improves with peptide length, and demonstrates that a multi-model consensus approach provides a rational framework for identifying robust structural hypotheses in the absence of experimental reference structures.
HighPlay2 is presented as a feasible framework for the early-stage design and screening of cyclic peptide candidates containing ncAAs, while further affinity maturation and experimental structural validation remain necessary.
Huitian Lin, Wentong Wang, Ning Zhu et al.· European journal of medicina...· 0 citations
A category-stratified, statistically powered benchmark comparing pose prediction from receptor conformational ensembles against AlphaFold2, used as a matched static-structure baseline, across 29 protein–ligand systems spanning cryptic-pocket, induced-fit, water-mediated, and autoimmune-indication target classes is presented.
Ryan Varghese, Pooja Tiwary, Krishil Oswal· bioRxiv· 0 citations
It is found that, while AF3 can perform well in favourable settings, this performance is uneven across applications and its predictions and use of confidence metrics will depend strongly on the specific application area and must be interpreted with respect to training-set overlap.
O. Follonier, Yan Liu, Pablo Campomanes et al.· bioRxiv· 1 citation
Cyclic peptides are a promising therapeutic modality, offering the potential to target challenging intracellular protein-protein interactions involved in cancer and other diseases. However, their clinical utility is frequently restricted by poor membrane permeability. While deep learning offers new methodologies to predict permeability, current models are limited by a reliance on 2D molecular representations that fail to capture the conformational flexibility inherent to macrocycles. Existing 3D resources also lack physics-based sampling of conformational dynamics across solvent environments that are critical for membrane permeability. To bridge this gap, we present CycPeptMPDB-4D, a comprehensive dataset comprising atomistic molecular dynamics trajectories for 5,160 structurally diverse cyclic peptides, including unnatural, N-methylated, and D-residues in circle and lariat topologies. Each peptide was simulated using the AMBER14SB force field in both explicit water and hexane environments for 50 nanoseconds to generate conformational ensembles in aqueous and membrane-mimicking phases. The trajectories capture the “chameleon-like” property, evidenced by markedly reduced conformational flexibility and polar surface area in the hydrophobic phase. Technical validation demonstrates that the simulated ensembles are in high agreement with experimental NMR data, covering NMR conformers within an RMSD of 1.6 Å. The dataset provides clustered ensembles, representative structures, and specialized descriptors such as desolvation free energy. This resource is designed to facilitate the development of deep learning models that incorporate 3D or 4D (trajectory- or ensemble-based) information to improve the prediction of cyclic peptide membrane permeability.
Wei Liu, Nguyen Hung Pham, Chandra S. Verma et al.· Scientific Data· 0 citations